Compare Davita Inc (DVA) vs iShares MSCI South Korea ETF (EWY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs iShares MSCI South Korea ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while iShares MSCI South Korea ETF trades at $178.76 (market cap $26.77B). The key difference: iShares MSCI South Korea ETF is far larger — about 2.4× Davita Inc's market cap, and iShares MSCI South Korea ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and iShares MSCI South Korea ETF for 46 Days on average.
| DVA | EWY | |
|---|---|---|
Market Cap | $11.28B | $26.77B |
Volume | 650,294 | 12,180,040 |
Sector | Health | Broad Market / Factor |
52-Week High | $240.96 | $219.20 |
52-Week Low | $103.87 | $80.72 |
Typical Hold Time | 113 Days | 46 Days |
Enterprise Value | $24.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
EWY (iShares MSCI South Korea ETF) trades at $183.72, down 1.44% amid mixed technical signals with neutral overall momentum. The ETF faces pressure from rising oil prices and global bond yields impacting South Korean semiconductor stocks, though AI-driven demand provides underlying support. Recent volatility around the 7,000 KOSPI level reflects ongoing tension between technology sector strength and macroeconomic headwinds.
Outlook remains cautiously optimistic given South Korea's strong corporate earnings and AI infrastructure growth, but concentrated exposure to Samsung and SK hynix creates sensitivity to memory cycle fluctuations. Key risks include persistent inflation pressures and global semiconductor demand volatility that could challenge near-term performance despite long-term AI tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About iShares MSCI South Korea ETF
EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.
Read more on EWY →
